Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level

Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

OBJECTIVES. The purpose of this study was to determine whether the impaired endothelium-dependent vasodilation of hypertensive patients is related to a specific defect of the muscarinic receptor or to a broader abnormality of the vascular endothelium. BACKGROUND. Patients with essential hypertension have abnormal endothelium-dependent vasodilator response to acetylcholine. However, whether this results from an isolated dysfunction of the endothelial cell muscarinic receptor is unknown. METHODS. The responses of the forearm vasculature to acetylcholine and substance P (endothelium-dependent agents acting on different receptors) and to sodium nitroprusside (a direct dilator of vascular smooth muscle) were studied in eight hypertensive patients (six men, two women; mean age [+/- SD] 50 +/- 12 years) and eight normal control subjects (four men, four women; mean age 49 +/- 9 years). To determine the nitric oxide contribution to substance P-induced vasodilation, the vascular responses to substance P were also measured after inhibition of nitric oxide synthesis with NG-monomethyl-L-arginine. Drugs were infused into the brachial artery, and forearm blood flow was measured by strain gauge plethysmography. RESULTS. The response to acetylcholine was significantly blunted in hypertensive patients (highest blood flow [mean +/- SD] 8.4 +/- 4 vs. 13.8 +/- 4 ml/min per 100 ml in control subjects, p < 0.03). Similarly, the vasodilator effect of substance P was significantly reduced in hypertensive patients (highest blood flow [mean +/- SD] 8.8 +/- 4 vs. 13.9 +/- 4 ml/min per 100 ml in control subjects, p < 0.03). A significant correlation was found between the maximal blood flow with acetylcholine and that with substance P (r = 0.68, p < 0.004). The vasodilator response to sodium nitroprusside was similar in patients and control subjects. The nitric oxide contribution to substance P-induced vasodilation was reduced in hypertensive patients, such that the responses to substance P measured during infusion of NG-monomethyl-L-arginine were not significantly different between the two groups. CONCLUSIONS. These findings indicate that the endothelial abnormality of patients with essential hypertension is not restricted to the muscarinic cell receptor.

This article has been cited by other articles:

				H. Kamran, L. Salciccioli, Eun Hee Ko, G. Qureshi, H. Kazmi, J. Kassotis, and J. Lazar Effect of Reactive Hyperemia on Carotid-Radial Pulse Wave Velocity in Hypertensive Participants and Direct Comparison With Flow-Mediated Dilation: A Pilot Study Angiology, February 1, 2010; 61(1): 100 - 106. [Abstract] [PDF]

				A. Soylu, K. Ozdemir, M. A. Duzenli, M. Yazici, and M. Tokac Impact on Diabetes Mellitus on the Epicardial Coronary Flow Velocity Assessed by the Thrombolysis in Myocardial Infarction Frame Count Angiology, August 1, 2009; 60(4): 431 - 440. [Abstract] [PDF]

				M. Seddon, N. Melikian, R. Dworakowski, H. Shabeeh, B. Jiang, J. Byrne, B. Casadei, P. Chowienczyk, and A. M. Shah Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo Circulation, May 26, 2009; 119(20): 2656 - 2662. [Abstract] [Full Text] [PDF]

				A. Barac, U. Campia, and J. A. Panza Methods for Evaluating Endothelial Function in Humans Hypertension, April 1, 2007; 49(4): 748 - 760. [Full Text] [PDF]

				M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]

				K. Lakhani, A. Leonard, A.M. Seifalian, and P. Hardiman Microvascular dysfunction in women with polycystic ovary syndrome Hum. Reprod., November 1, 2005; 20(11): 3219 - 3224. [Abstract] [Full Text] [PDF]

				K. Inokuchi, Y. Hirooka, H. Shimokawa, K. Sakai, T. Kishi, K. Ito, Y. Kimura, and A. Takeshita Role of Endothelium-Derived Hyperpolarizing Factor in Human Forearm Circulation Hypertension, November 1, 2003; 42(5): 919 - 924. [Abstract] [Full Text] [PDF]

				J. Gomez-Cerezo, J. J. Rios Blanco, I. Suarez Garcia, P. Moreno Anaya, P. Garcia Raya, E. Vazquez-Munoz, and F. J. Barbado Hernandez Noninvasive Study of Endothelial Function in White Coat Hypertension Hypertension, September 1, 2002; 40(3): 304 - 309. [Abstract] [Full Text] [PDF]

				M. G. Modena, L. Bonetti, F. Coppi, F. Bursi, and R. Rossi Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J. Am. Coll. Cardiol., August 7, 2002; 40(3): 505 - 510. [Abstract] [Full Text] [PDF]

				N. Tzemos, P.O. Lim, and T.M. MacDonald Is exercise blood pressure a marker of vascular endothelial function? QJM, July 1, 2002; 95(7): 423 - 429. [Full Text] [PDF]

				C. A DeSouza, C. M Clevenger, J. J Greiner, D. T Smith, G. L Hoetzer, L. F Shapiro, and B. L Stauffer Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans J. Physiol., July 1, 2002; 542(1): 255 - 262. [Abstract] [Full Text] [PDF]

				H. Tomiyama, Y. Kimura, R. Okazaki, T. Kushiro, M. Abe, Y. Kuwabara, H. Yoshida, S. Kuwata, T. Kinouchi, and N. Doba Close Relationship of Abnormal Glucose Tolerance With Endothelial Dysfunction in Hypertension Hypertension, August 1, 2000; 36(2): 245 - 249. [Abstract] [Full Text] [PDF]

				H. Suzuki, H. Ikezaki, D. Hong, and I. Rubinstein PGH2-TxA2-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension J Appl Physiol, June 1, 2000; 88(6): 1983 - 1988. [Abstract] [Full Text] [PDF]

				J C Chambers, A McGregor, J Jean-Marie, and J S Kooner Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians Heart, May 1, 1999; 81(5): 501 - 504. [Abstract] [Full Text]

				F. Perticone, R. Ceravolo, R. Maio, G. Ventura, S. Iacopino, G. Cuda, P. Mastroroberto, M. Chello, and P. L. Mattioli Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients Cardiovasc Res, January 1, 1999; 41(1): 299 - 306. [Abstract] [Full Text] [PDF]

				C. Metais, J. Li, J. Li, M. Simons, and F. W. Sellke Effects of coronary artery disease on expression and microvascular response to VEGF Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1411 - H1418. [Abstract] [Full Text] [PDF]

				R. O. Cannon III Role of nitric oxide in cardiovascular disease: focus on the endothelium Clin. Chem., August 1, 1998; 44(8): 1809 - 1819. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential Hypertension Circulation, June 9, 1998; 97(22): 2222 - 2229. [Abstract] [Full Text] [PDF]

				C. Cardillo and J. A Panza Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension Vascular Medicine, May 1, 1998; 3(2): 138 - 144. [Abstract] [PDF]

				J. P Noon, B. R Walker, M. F Hand, and D. J Webb Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin Cardiovasc Res, May 1, 1998; 38(2): 480 - 484. [Abstract] [Full Text] [PDF]

				D. E Newby, R. A Wright, P. Dawson, C. A Ludlam, N. A Boon, K. A.A Fox, and D. J Webb The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man Cardiovasc Res, May 1, 1998; 38(2): 485 - 492. [Abstract] [Full Text] [PDF]

				C. Cardillo, C. M. Kilcoyne, A. A. Quyyumi, R. O. Cannon III, and J. A. Panza Selective Defect in Nitric Oxide Synthesis May Explain the Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension Circulation, March 10, 1998; 97(9): 851 - 856. [Abstract] [Full Text] [PDF]

				U. C. Kopp, M. Z. Cicha, D. M. Farley, L. A. Smith, and B. S. Dixon Renal Substance P Containing Neurons and Substance P Receptors Impaired in Hypertension Hypertension, March 1, 1998; 31(3): 815 - 822. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, S. Uleri, A. Magagna, and A. Salvetti Lacidipine Restores Endothelium-Dependent Vasodilation in Essential Hypertensive Patients Hypertension, December 1, 1997; 30(6): 1606 - 1612. [Abstract] [Full Text]

				C. Cardillo, C. M. Kilcoyne, A. A. Quyyumi, R. O. Cannon III, and J. A. Panza Decreased Vasodilator Response to Isoproterenol During Nitric Oxide Inhibition in Humans Hypertension, October 1, 1997; 30(4): 918 - 921. [Abstract] [Full Text]

				A. A. Quyyumi, D. Mulcahy, N. P. Andrews, S. Husain, J. A. Panza, and R. O. Cannon III Coronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia: Comparison of Acetylcholine and Substance P Circulation, January 7, 1997; 95(1): 104 - 110. [Abstract] [Full Text]

				C. E. Garcia, C. M. Kilcoyne, C. Cardillo, R. O. Cannon III, A. A. Quyyumi, and J. A. Panza Effect of Copper-Zinc Superoxide Dismutase on Endothelium-Dependent Vasodilation in Patients With Essential Hypertension Hypertension, December 1, 1995; 26(6): 863 - 868. [Abstract] [Full Text]

				J. A. Panza, C. E. Garcia, C. M. Kilcoyne, A. A. Quyyumi, and R. O. Cannon III Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension : Evidence That Nitric Oxide Abnormality Is Not Localized to a Single Signal Transduction Pathway Circulation, March 15, 1995; 91(6): 1732 - 1738. [Abstract] [Full Text]